SAN DIEGO (AP) _ Cytori Therapeutics Inc. (CYTX) on Thursday reported a loss of $4.9 million in its fourth quarter.
On a per-share basis, the San Diego-based company said it had a loss of 24 cents.
The developer of cell therapies posted revenue of $1.5 million in the period.
For the year, the company reported that its loss widened to $22 million, or $1.28 per share. Revenue was reported as $4.7 million.
In the final minutes of trading on Thursday, the company's shares hit $1.64. A year ago, they were trading at $2.88.
This story was generated by Automated Insights (http://automatedinsights.com/ap) using data from Zacks Investment Research. Access a Zacks stock report on CYTX at https://www.zacks.com/ap/CYTX
Keywords: Cytori Therapeutics, Earnings Report